K receptor opioid peptides
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CARA THERAPEUTICS
- Publication Date
- 2001-02-07
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
[0001] The present invention relates generally to synthetic opioid peptides, and in particular to opioid peptides that are highly selective κ receptor activators, and more particularly to activators that (a) do not penetrate the brain, and (b ) has long-term antinociceptive activity in vivo. Background of the invention
[0002] The kappa opioid receptor (KOR) is present in the brain, spinal cord, central and peripheral nerve endings, (somatic and visceral) primary sensory afferent nerve cell bodies, and immune cells. Molecules that activate KOR are generally referred to as kappa activators.
[0003] Activation of KOR in the brain is known to produce analgesic effects. Based on this finding, attempts were made to develop brain-permeable non-peptide κ activators as new analgesics to avoid the side effects (constipation, respiratory depression) of morphine analogs acting on the mu opioid receptor (MOR). , dependence and addiction). Such compounds have bee...